Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331432 · ClinicalTrials.gov registry record · NA
Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03331432 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 8 participants.
The verdict
NCT03331432, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the present study is to determine if use of dietary supplement tauroursodeoxycholic acid enhances insulin-stimulated leg blood flow and glucose disposal.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Tauroursodeoxycholic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-10-28 |
| Est. Completion | 2018-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03331432
The ClinicalTrials.gov registry entry for NCT03331432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03331432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03331432 about?
NCT03331432 is a clinical study titled "Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function". The purpose of the present study is to determine if use of dietary supplement tauroursodeoxycholic acid enhances insulin-stimulated leg blood flow and glucose disposal.
What is the current status of trial NCT03331432?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-10-28. Estimated completion is 2018-02-14.
What interventions are being tested in trial NCT03331432?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Tauroursodeoxycholic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03331432?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.